Pilot Conformance Projects Under Development

QIBA Profile Conformance

{This content will eventually be available on the RSNA.org website.}

QIBA Profiles that are at least at consensus level (link to wiki page on development of a Profile) are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile. There are two different ways to show QIBA Profile conformance:

• Self – attestation
• Certification service

The basic process flow is shown below:

Before starting conformance testing, please Email QIBA

CT: Lung Tumor Volume (Advanced Disease)

• Profile
• CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22
• Checklist

• CT Conformance Checklist (can also refer to Appendix C in the Profile document - pg 42)
• Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
  • CT Conformance Testing Supplement, 2019-11-11

• Report Template

FDG-PET: Solid Tumor SUV

• Profile
• FDG-PET/CT for Response to Cancer Therapy 2016-11-18
• Checklist
• QIBA FDG-PET/CT Conformance Testing Checklist, 2019-11-11
• Report Template

MR: ADC-DW MR Lesions in Four Organs

• Profile
• Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05
• Checklist
• QIBA DWI-MRI Conformance Checklist, 2019-11-11
  • QIBA DWI Conformance Testing Supplement #1, 2019-11-11
  • QIBA DWI Conformance Testing Supplement #2, 2019-11-11
• Report Template

==QIBA Profiles that are available for QIBA or designee testing:==

• CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18
• https://www.rsna.org/en/research/quantitative-imaging-biomarkers-alliance/qiba-conformance-certification-services